Over the past years, LLG showed a tremendous growth trajectory, both organically and inorganically. With a double-digit organic growth and 7 acquisitions since 2020, LLG more than doubled both revenues and EBITDA, reaching total sales of about €160 million in 2022. With further exclusive acquisitions in the pipeline, the next milestone of €250 million in revenues is almost at touch.
The next leapfrog in the development of the group will be strong operational integration, further leveraging the multiple synergies within the subsidiaries. For this growth phase, the group implements a planned management change, bringing in new talent with the respective skill-focus.
Thomas Lang, CEO of the group since April 2020, will resign per end March and take over new challenges outside LLG. The group is very happy about the strong contribution Thomas made during his 3 years’ assignment, especially with clearly focusing strategy, positioning, and M&A-activities on Life Science and Health Care as key areas of activity, visible in the rebranding to LLG that he designed and executed.
His responsibilities as LLG Group CEO will be taken over by Stefan Glebke as of February 15th, 2023. Stefan shows an unanimous success record during his long career at BMW group, including numerous international assignments. He last served as a Group CFO, CRO and Member of the Board at SHARE NOW. With his outstanding experience in the US market, among many other strengths, he is perfectly fitted to oversee the American entities of the group that already today make up for more than 60% of the groups’ results.
On the operational side, Michael Boos will take over the new position as a COO to the LLG group. Michael joined LLG in October 2022 as CEO to the Life Science branch headquartered in Munich. He will allocate half of his capacity to the Group-wide operational integration. Being in the logistics industry for decades, e.g., as CEO at Rhenus High Tech and Health Care and CEO Germany of ID Logistics, he has the experienced background to fully meet the COO-tasks.
The next leapfrog in the development of the group will be strong operational integration, further leveraging the multiple synergies within the subsidiaries. For this growth phase, the group implements a planned management change, bringing in new talent with the respective skill-focus.
Thomas Lang, CEO of the group since April 2020, will resign per end March and take over new challenges outside LLG. The group is very happy about the strong contribution Thomas made during his 3 years’ assignment, especially with clearly focusing strategy, positioning, and M&A-activities on Life Science and Health Care as key areas of activity, visible in the rebranding to LLG that he designed and executed.
His responsibilities as LLG Group CEO will be taken over by Stefan Glebke as of February 15th, 2023. Stefan shows an unanimous success record during his long career at BMW group, including numerous international assignments. He last served as a Group CFO, CRO and Member of the Board at SHARE NOW. With his outstanding experience in the US market, among many other strengths, he is perfectly fitted to oversee the American entities of the group that already today make up for more than 60% of the groups’ results.
On the operational side, Michael Boos will take over the new position as a COO to the LLG group. Michael joined LLG in October 2022 as CEO to the Life Science branch headquartered in Munich. He will allocate half of his capacity to the Group-wide operational integration. Being in the logistics industry for decades, e.g., as CEO at Rhenus High Tech and Health Care and CEO Germany of ID Logistics, he has the experienced background to fully meet the COO-tasks.
